Ana Radeljevic
Direktor/Vorstandsmitglied bei MERRIMACK PHARMACEUTICALS, INC.
Aktive Positionen von Ana Radeljevic
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 06.06.2022 | - |
| Independent Dir/Board Member | 06.06.2022 | - | |
ADRx, Inc.
 ADRx, Inc. Pharmaceuticals: MajorHealth Technology ADRx, Inc. is a biopharmaceutical company. The firm advances drug candidates for Alzhiemer’s disease, systemic amyloidosis and ovarian cancer. The company was founded by Gary Wilcox and David Eisenberg and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01.09.2021 | - |
Karriereverlauf von Ana Radeljevic
Ehemalige bekannte Positionen von Ana Radeljevic
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| REVVITY, INC. | Corporate Officer/Principal | 01.01.2014 | 01.01.2016 |
Ausbildung von Ana Radeljevic
| Syracuse University | Masters Business Admin |
| Old Dominion University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| REVVITY, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
ADRx, Inc.
ADRx, Inc. Pharmaceuticals: MajorHealth Technology ADRx, Inc. is a biopharmaceutical company. The firm advances drug candidates for Alzhiemer’s disease, systemic amyloidosis and ovarian cancer. The company was founded by Gary Wilcox and David Eisenberg and is headquartered in Thousand Oaks, CA. | Health Technology |
- Börse
- Insiders
- Ana Radeljevic
- Erfahrung